article graphic

News & Insights

Filtern nach:

Filter

Glass.Mapper.Sc.Fields.Image?.Alt
Life Sciences & Healthcare

Patents diary June 2020: UK Supreme Court holds Regeneron's transgenic mice patents invalid

26. Juni 2020
IN-DEPTH ANALYSIS

von Dr Paul England

Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Synapse

Territorial licensing: "start at the end before you begin"

25. Juni 2020
IN-DEPTH ANALYSIS

von Justyna Ostrowska-Krupa

Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Life Sciences & Healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 2: Investment and cash flow

23. Juni 2020
IN-DEPTH ANALYSIS

von Adrian Toutoungi und Josef Fuss

Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Life Sciences & Healthcare

Impact of COVID-19 on venture-backed biotech companies – Part 1: Operational issues

22. Juni 2020
IN-DEPTH ANALYSIS

von Adrian Toutoungi und Josef Fuss

Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Synapse

A missed chance

14. Juni 2020
IN-DEPTH ANALYSIS
Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Synapse

NHS can procure drugs for use outside of their approved indications if it's cheaper, court says

4. Mai 2020
IN-DEPTH ANALYSIS

von Justyna Ostrowska-Krupa

Klicken Sie hier für Details
Glass.Mapper.Sc.Fields.Image?.Alt
Synapse

Patents diary: April 2020

30. April 2020
QUICK READ

von Dr Paul England

Klicken Sie hier für Details
Life Sciences & Healthcare

Everything biologic and biosimilar in-house counsel need to know about COVID-19

29. April 2020

von Matthew Royle, Ph.D.

Klicken Sie hier für Details
blueprints
Interface - The latest in life sciences

Patent pools: an easy licensing option for COVID-19 drugs and SARS CoV 2 vaccines?

An exploration of patent pools, R&D and current initiatives.

22. April 2020
IN-DEPTH ANALYSIS

2 von 6 Insights

Klicken Sie hier für Details